NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease

NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease

Mesenchymal stem cells (MSCs) are becoming more popular in therapy. Therefore, in-depth studies on mesenchymal stem cells in therapy are urgently needed. However, the difficulty in culturing and propagating MSCs in vitro complicates potential studies on MSCs in a murine model. OP9 cells are a stroma...

Full description

Bibliographic Details
Main Authors: Yutong Chen, Weicheng Meng, Guangming Ren, Ning An, Jing Zhang, Zhixin Liu, Xiaoshuang Wu, Wen Yin, Xingbin Hu, Zheng Liu, Fan Feng, Yaozhen Chen
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Heliyon
Subjects:
OP9 cell
NLRP3 inflammasome
IL-1β
Pyroptosis
Inflammatory bowel disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023052465

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023052465

Similar Items